EUVIMEDEUVIMED entdecken
Beobachtungsstudie

An endometrial thickness of

Sae Jin Song iD, Carina Miles, Sathana Ponnampalam, Katherine Sowden, Asima Shafique, Charlotte Oyston iD

Australian and New Zealand Journal of Obstetrics and Gynaecology · 2025

DOI: 10.1111/ajo.13900 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Australian and New Zealand Journal of Obstetrics and Gynaecology, 2025. Verfasst von Sae Jin Song und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynaecology, Middlemore Hospital, Auckland, New Zealand. Hauptthemen laut MEDLINE: Endometrium, Endometrial Neoplasms, Uterine Hemorrhage, Precancerous Conditions. Die Arbeit nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

It remains unclear if there is an endometrial thickness (ET) threshold below which malignancy can be excluded. Guidance on whether endometrial biopsy is needed based on ET varies among regions in New Zealand and there is a desire to standardise guidance nationwide. This study evaluates the potential impact of limiting endometrial biopsy in pre‐menopausal persons with abnormal uterine bleeding (AUB) to those with an ET of less than 12 mm.

Aims

To determine the number of pre‐menopausal patients with AUB with an ET of less than 12 mm undergoing endometrial sampling annually and assess the prevalence of pathology among these patients. Materials and Methods Endometrial samples from patients aged 18–50 years processed at a tertiary hospital between 15/06/2022 and 13/06/2023 were identified via a pathology lab search. Clinical, radiologic, and pathological data were obtained by case note review for those with AUB whose ET was less than 12 mm.

Results

Of 1271 endometrial samples, 355 patients met the eligibility criteria, and 2.2% of these were cancerous (three cases) or pre‐malignant (five cases).

Conclusions

If sampling thresholds would change to not perform biopsies in those with an ET of less than 12 mm, eight cases of treatable disease would be missed in pre‐menopausal people. This represents 13.6% of all endometrial cancers diagnosed in pre‐menopausal people in the same time period. There is no ET cut‐off to reliably exclude high‐risk pathology and endometrial sampling should be performed in all cases of AUB with risk factors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EndometriumEndometrial NeoplasmsUterine HemorrhagePrecancerous ConditionsHumansFemaleAdultMiddle AgedBiopsyPremenopauseYoung AdultAdolescentNew Zealand

Stichwörter der Autor:innen

abnormal uterine bleedingendometrial hyperplasiaendometrial samplingendometrial thicknessultrasonography, transvaginal

Autor:innen und Institutionen

  • Department of Obstetrics and Gynaecology, Middlemore Hospital, Auckland, New Zealand.
  • Department of Histopathology, Middlemore Hospital, Auckland, New Zealand.
  • Department of Obstetrics and Gynaecology, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
  • Department of Obstetrics and Gynaecology, Te Toka Tumai, Auckland, New Zealand.

ORCID-Profile: Sae Jin Song, Charlotte Oyston

Zitieren

APA

Song, S. J., Miles, C., Ponnampalam, S., Sowden, K., Shafique, A., & Oyston, C. (2025). An endometrial thickness of. Australian and New Zealand Journal of Obstetrics and Gynaecology. https://doi.org/10.1111/ajo.13900

Vancouver

Song SJ, Miles C, Ponnampalam S, Sowden K, Shafique A, Oyston C. An endometrial thickness of. Australian and New Zealand Journal of Obstetrics and Gynaecology. 2025. doi:10.1111/ajo.13900

BibTeX
@article{Song2025,
  author = {Song, Sae Jin and Miles, Carina and Ponnampalam, Sathana and Sowden, Katherine and Shafique, Asima and Oyston, Charlotte},
  title = {An endometrial thickness of},
  journal = {Australian and New Zealand Journal of Obstetrics and Gynaecology},
  year = {2025},
  doi = {10.1111/ajo.13900}
}
Kostenlos starten →